The messenger substance beta-interferon, which is found in the body, is part of the body’s defense against infections and is often used to treat multiple sclerosis. The novel corona virus suppresses its production in the body. Inhalation takes the protein directly to the patient’s lungs – and is said to trigger a robust immune response to the virus, even in patients who are already weakened by the infection.
“The results confirm our belief that beta-interferon as an inhalation drug has tremendous potential to restore the lung’s immune response,” said lung specialist Tom Wilkinson of the University of Southampton. University of Glasgow expert Naveed Sattar spoke of a potentially groundbreaking development. However, he pointed out that a significantly larger study was necessary for a more precise assessment.